$HCCC News
Last published 4y ago
- 4y agoHCCCHCCCUAlpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business CombinationPR NewswireJERUSALEM and WILMINGTON, Del., March 7, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and Healthcare Capital Corp. (NASDAQ:HCCC) ("HCCC"), a special purpose acqui
- 4y agoHCCCHCCCUHCCCWHealthcare Capital Corp. and Alpha Tau Medical Ltd. Announce Stockholder Approval of the Business CombinationGlobeNewswireNEW YORK and JERUSALEM, ISRAEL , Feb. 22, 2022 (GLOBE NEWSWIRE) -- Healthcare Capital Corp. (NASDAQ:HCCC, HCCCW, and HCCCU))) ("HCCC") and Alpha Tau Medical Ltd. ("Alpha Tau"), an Israeli medical device company that focuses on research, development,
- 4y agoHCCCHCCCUHCCCWHealthcare Capital Corp. Announces Adjournment of Special Meeting of StockholdersGlobeNewswireNEW YORK, NY, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Healthcare Capital Corp. (NASDAQ:HCCC, HCCCW, and HCCCU))) ("HCCC") today announced that on February 18, 2022, it convened and then adjourned, without conducting any other business, its special meeting o
- 4y agoHCCCHCCCUHCCCWHealthcare Capital Corp. Announces Adjournment of Special Meeting of StockholdersGlobeNewswireNEW YORK, NY, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Healthcare Capital Corp. (NASDAQ:HCCC, HCCCW, and HCCCU))) ("HCCC") today announced that on February 15, 2022 it convened and then adjourned, without conducting any other business, its special meetin
- 4y agoHCCCHCCCUAlpha Tau Announces New Research Collaboration to Study the Potential of Alpha DaRT to Enhance Immune Stimulation in the Treatment of Breast CancerPR NewswireJERUSALEM, Jan. 20, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has signed a sponsored research agreement with investigators at The Univ
- 4y agoHCCCHCCCUHCCCWHealthcare Capital Corp Announces Special Meeting Date for Proposed Business Combination with Alpha Tau Medical Ltd.GlobeNewswireSpecial Meeting Scheduled for February 15, 2022 The combined company will be named Alpha Tau Medical Ltd. and remain listed on the NASDAQ under ticker DRTS NEW YORK, New York and JERUSALEM, Israel, Jan. 19, 20
- 4y agoHCCCAlpha Tau Announces Results of First US Clinical Trial of Alpha DaRT™ in Malignant Skin & Soft Tissue Cancers, Showing Complete Response in All Ten Treated Tumors at Approximately 12 Weeks and No Product-Related Serious Adverse EventsPR NewswireJERUSALEM, Jan. 10, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that all ten patients in its US multi-center pilot trial of the Alpha DaRT for
- 4y agoHCCCHCCCUAlpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck CancerPR NewswireJERUSALEM, Jan. 3, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has been notified by HekaBio K.K., its clinical trial partner in Japan, t
- 5y agoHCCCAlpha Tau Announces Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)PR NewswireJERUSALEM, Nov. 3, 2021 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced today that it has enrolled its first patient in the combination study of Alpha DaRT an
- 5y agoHCCCAlpha Tau Announces Completion of Enrollment in First US Clinical Trial of Alpha DaRT™ and Achievement of First Primary ObjectivePR NewswireJERUSALEM, Oct. 25, 2021 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced today that its US pilot trial for skin cancer has completed enrollment as planned. This an
- 5y agoCNDFPACHCAQHCCCMoore Kuehn Encourages CND, HCAQ, HCCC and FPAC Investors to Contact Law FirmPR NewswireNEW YORK, July 13, 2021 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shar
- 5y agoHCCCAlpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid Tumors Through the Precision Delivery of Alpha RadiationPR Newswire- Alpha Tau's proprietary Alpha DaRT™ is designed to deliver uniquely potent alpha radiation to destroy solid tumors with localized precision, sparing surrounding healthy tissue, thereby maintaining cancer patients' quality of life. Alpha DaRT™ has
- 5y agoHCCCHealthcare Capital Corp. Announces the Separate Trading of its Class A Common Stock and WarrantsGlobeNewswireWilmington, DE, March 04, 2021 (GLOBE NEWSWIRE) -- Healthcare Capital Corp. (the “Company”) announced today that, commencing March 8, 2021, holders of the 27,500,000 units sold in the Company’s...
- 5y agoHCCCHealthcare Capital Corp. Announces Closing of Upsized $275,000,000 Initial Public OfferingGlobeNewswireWilmington, DE, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Healthcare Capital Corp. (the “Company”) announced today that it closed its upsized initial public offering of 27,500,000 units at $10.00 per unit,...
- 5y agoHCCCHealthcare Capital Corp. Announces Pricing of Upsized $240 Million Initial Public OfferingGlobeNewswireWilmington, DE, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Healthcare Capital Corp. (the “Company”), a newly incorporated blank check company, today announced the pricing of its upsized initial public...